Experimental / RUOAugust 5, 2026
MOTS-c
Mitochondrial open reading frame of 12S rRNA-c
Longevity claims · Exercise claims
Tier 3Unapproved / RUO
MOTS-c + Humanin + Elamipretide
Mito Stack. This name is not standardized.
No adequate human combination evidence was identified in the static MVP review. Component-level findings do not transfer to the combination.
Unapproved / RUO. No approval is implied by use of a commercial or community name.
No validated human combination trial identified
Compatibility, sterility and stability are not established across marketed variants
This named stack should be evaluated as an unstandardized combination. It does not inherit the evidence score of its strongest component.
Mitochondrial open reading frame of 12S rRNA-c
Longevity claims · Exercise claims
HN peptide
Neuroprotection research · Longevity claims
SS-31
Barth syndrome · Mitochondrial disease research